Spok Holdings, Inc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Spok Holdings, Inc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	180	171	169	160	148	142	135	139	138	140
Cost of revenue	30.6	28.4	32.4	32.6	30.9	32.5	28.3	27.1	28.7	29.8
Gross profit	149	143	137	128	117	110	106	112	109	110
Research and development	13.5	18.7	24.5	27.5	15.7	17.5	13.6	10.7	11.7	12.2
Selling and marketing	24.8	22.8	24.6	23.2	20.3	21.1	16.3	16.7	16.2	17.7
General and administrative	42.8	47.4	49.1	43.3	39.6	43.5	37.8	31.1	31.2	31.8
Operating income	22.2	10.7	-3.17	-15.8	-22.7	-27.7	0.24	21.2	19	19.7
Interest income							0.59	1.1	1.15	0.82
Other non-operating income	0.54	0.13	-0.65	0.74	0.21	0.07	0.17	-0	-0.09	0.91
Pre-tax income	23	11.6	-2.19	-13.4	-21.8	-27.3	1	22.3	20	21.4
Income tax	8.99	26.9	-0.71	-2.66	22.5	-5.15	-20.9	6.66	5.07	5.56
Net income	14	-15.3	-1.48	-10.8	-44.2	-22.2	21.9	15.7	15	15.9
EBITDA	35.1	22.3	7.6	-6.56	-13.6	-17.3	3.81	25.7	23.1	23.1
EPS, basic	0.68	-0.76	-0.08	-0.56	-2.32	-1.14	1.11	0.79	0.74	0.77
EPS, diluted	0.68	-0.76	-0.08	-0.56	-2.32	-1.14	1.09	0.77	0.73	0.75
Shares, basic (weighted)	20.6	20.2	19.7	19.1	19	19.4	19.7	20	20.2	20.6
Shares, diluted (weighted)	20.6	20.2	19.7	19.1	19	19.4	20	20.3	20.6	21.1
Dividend per share	0.75	0.50	0.50	0.50	0.50	0.50	1.25	1.25	1.25	1.25

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	122	103	83.3	47.4	48.7	44.6	35.8	32	29.1	25.3
Short-term investments			3.96	29.9	30	15	0
Receivables	23.7	29.7	32.4	30.2	29.9	26.9	26.9	23.3	22	22.6
Inventory	2	1.67	1.71	1
Other current assets	4.38	5.75	2.67	2.71	1.27	0.92	0.59	0.7	0.84	1.05
Total current assets	156	144	131	118	119	94.1	70.1	63.9	61.3	57.9
Property, plant and equipment	12.8	13.4	10.4	8	7.82	6.75	8.22	7.32	5.95	5.72
Lease right-of-use assets			0	16.3	14	15.8	13.9	10.5	8.25	6.48
Goodwill	133	133	133	124	99.2	99.2	99.2	99.2	99.2	99.2
Intangible assets	10.8	7.92	5.42	2.92	0.42	0	0	0
Other non-current assets	2.51	1.68	1.45	1.81	0.98	0.71	0.75	0.51	0.74	0.32
Total assets	388	348	328	320	277	248	244	228	217	206
Accounts payable	1.91	1.31	2.01	3.62	6.69	5.29	5.88	5.97	5.63	3.98
Accrued liabilities	13.3	11	11.3	11.7	14.1	13.9	11.6	7.28	7.36	7.36
Deferred revenue	29.1	28.9	26.1	25.9	27.7	25.6	27.3	26.3	28.4	30.5
Total current liabilities	56.3	48.3	44.9	51.2	57.4	55	54.4	48	48.8	49.1
Lease liabilities			0	11.6	9.46	11.9	10.6	6.9	5.87	4.26
Other non-current liabilities	8.92	8.08	1.7	0.96	2.49	1.23	1.11	1.81	1.77	1.46
Total liabilities	66	57.5	53.2	69.8	76.7	74.5	73.4	63.9	62.4	59.7
Paid-in capital	105	99.8	90.6	86.9	91.8	97.3	99.9	103	106	108
Retained earnings	217	192	185	165	110	78	73.1	62.6	50.8	39.9
Treasury stock	-85.5
Other comprehensive income		-1.09	-1.3	-1.6	-1.45	-1.59	-1.91	-1.76	-1.78	-1.76
Shareholders' equity	322	291	275	250	200	173	171	164	155	146
Total equity	322	291	275	250	200	173	171	164	155	146
Total liabilities and equity	388	348	328	320	277	248	244	228	217	206
Shares outstanding	20.5	20.1	19.4	19.1	19.4	19.8	19.7	20	20.3	20.6

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	14	-15.3	-1.48	-10.8	-44.2	-22.2	21.9	15.7	15	15.9
Depreciation and amortization	13	11.6	10.8	9.25	9.06	10.4	3.57	4.5	4.15	3.43
Stock-based compensation	0.85	3.69	4.95	3.64	5.51	7.24	3.83	4.06	4.96	5.01
Deferred income tax	6.93	25.4	-1.69	-3.25	22.5	-5.48	-20.9	6.38	4.57	5.17
Change in receivables	-1.79	-9.65	-0.92	0.96	-1.59	1.83	-1.76	2.58	0.51	-1.96
Change in payables	1.19	-3.28	-1.73	0.74	4.02	-0.68	-2.26	-5.22	-1.18	-1.74
Cash from operations	37.6	15.5	10.3	11.7	26.2	7.97	6.46	26.2	28.9	28.9
Capital expenditures	-6.25	-9.21	-5.92	-4.84	-3.46	-4.39	-3.78	-3.42	-3.21	-3.75
Purchases of investments	-3.98	-3.96	-3.91	-59.4	-59.9	-45	-15	0	0
Cash from investing	-8.23	-9.17	-5.83	-30.2	-14.6	-0.23	11.3	-3.42	-3.21	-3.05
Share buybacks	-6.49	-10	-13.5	-6.58	0	0
Dividends paid	-10.3	-15.2	-10.1	-9.82	-9.77	-10	-25	-25.6	-26.4	-27.3
Cash from financing	-16.7	-25	-24.3	-17.2	-10.4	-11.8	-26.2	-26.7	-28.5	-29.8
Exchange rate effect	-0.11	0.01	-0.05	-0.3	0.15	-0.14	-0.32	0.15	-0.02	0.03
Net change in cash	14.5	-18.6	-19.8	-36	1.37	-4.15	-8.83	-3.77	-2.84	-3.87
Free cash flow	31.3	6.3	4.4	6.86	22.7	3.58	2.68	22.8	25.7	25.2
Income taxes paid	0.7	2.62	1.06	0.9	0	-0.13	0.22	0.2	0.6	0.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $10.46 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	78.1%	Gross profit / revenue.
Operating margin	11.9%	Operating income / revenue.
EBITDA margin	14.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	12.5%	Pre-tax income / revenue.
Net margin	9.0%	Net income / revenue.
FCF margin	18.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	21.0%	Cash from operations / revenue.
Effective tax rate	28.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	8.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	6.3%	Net income / average total assets.
Return on invested capital (ROIC)	9.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	9.5%	Research and development expense / revenue.
Stock-based pay / revenue	3.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.3%	Capital expenditures / revenue.
D&A / revenue	2.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	1.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-1.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	0.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	1.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-1.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	3.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	335.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	0.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	82.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	6.1%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-10.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	2.7%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-11.7%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	0.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	64.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	2.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-2.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	111.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	2.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	20.1%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-5.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-5.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-6.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-5.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-5.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-5.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	2.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	2.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.09x	Current assets / current liabilities.
Quick ratio	0.87x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.36x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	28.5%	Total liabilities / total assets.
Working capital	$4.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	50.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	$40.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.70x	Revenue / average total assets.
Fixed asset turnover	25.4x	Revenue / average property, plant and equipment.
Receivables turnover	5.79x	Revenue / average receivables.
Days sales outstanding	63 days	365 x average receivables / revenue.
Days payables	55 days	365 x average accounts payable / cost of revenue.
FCF conversion	207.6%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	11.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.58	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$6.45	Revenue / diluted weighted shares.
FCF per share	$1.20	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.36	Cash from operations / diluted weighted shares.
Book value per share	$6.69	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$1.95	Tangible book value / shares outstanding.
Cash per share	$0.79	(Cash + short-term investments) / shares outstanding.
Payout ratio	223.3%	Dividends paid / net income, when net income is positive.
Dividends / FCF	107.6%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$218.8M	Share price x shares outstanding.
Enterprise value	$202.2M	Market cap + total debt - cash - short-term investments.
P/E	17.9x	Market cap / net income. Only when net income is positive.
P/S	1.61x	Market cap / revenue.
P/B	1.56x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	5.38x	Market cap / tangible book value, when positive.
P/FCF	8.61x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	7.66x	Market cap / cash from operations, when positive.
EV/Sales	1.49x	Enterprise value / revenue.
EV/EBIT	12.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	10.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	7.96x	Enterprise value / free cash flow, when both are positive.
FCF yield	11.6%	Free cash flow / market cap.
Earnings yield	5.6%	Net income / market cap (the inverse of P/E).
Dividend yield	12.5%	Dividends paid over the period / market cap.
Shareholder yield	12.5%	(Dividends paid + share buybacks) / market cap.

What was Spok Holdings, Inc's revenue in fiscal 2025?

Spok Holdings, Inc reported revenue of $139.7M for fiscal 2025, 1.5% higher than the year before.

Was Spok Holdings, Inc profitable in fiscal 2025?

Yes. Net income was $15.9M, a net margin of 11.4%.

How much free cash flow did Spok Holdings, Inc generate in fiscal 2025?

Cash from operations of $28.9M minus capital expenditures of $3.8M left free cash flow of $25.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Spok Holdings, Inc